Literature DB >> 10525473

HIV-1 nuclear import: in search of a leader.

M I Bukrinsky1, O K Haffar.   

Abstract

The ability of HIV-1 to use host cell nuclear import machinery to translocate the viral pre-integration complex into the cell nucleus is the critical determinant in the replication of the virus in non-dividing cells, such as macrophages. In this review, we describe the viral and cellular factors involved in this process. The available data suggest that the process of HIV-1 nuclear import is driven by interaction between nuclear localization signals (NLSs) present on viral proteins matrix and integrase and the cellular NLS receptor, karyopherin alpha. However, this interaction by itself is weak and insufficient to insure effective import of the pre-integration complex. Viral protein R (Vpr) functions to increase the affinity of interaction between viral NLSs and karyopherin alpha, thus substantially enhancing the karyophilic potential of the pre-integration complex. Interestingly, some cells, in particular HeLa, seem to contain a factor that can substitute for the Vpr's activity, making HIV-1 replication in such cells Vpr-independent. We also describe a class of novel anti-HIV compounds that target the NLSs of HIV-1 and effectively block viral replication in T cells and macrophages.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10525473     DOI: 10.2741/bukrinsky

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  14 in total

1.  Integrase mediates nuclear localization of Ty3.

Authors:  S S Lin; M H Nymark-McMahon; L Yieh; S B Sandmeyer
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

2.  Optimization of the transductional efficiency of lentiviral vectors: effect of sera and polycations.

Authors:  Warren Denning; Suvendu Das; Siqi Guo; Jun Xu; John C Kappes; Zdenek Hel
Journal:  Mol Biotechnol       Date:  2013-03       Impact factor: 2.695

3.  Gene therapy, early promises, subsequent problems, and recent breakthroughs.

Authors:  Saeideh Razi Soofiyani; Behzad Baradaran; Farzaneh Lotfipour; Tohid Kazemi; Leila Mohammadnejad
Journal:  Adv Pharm Bull       Date:  2013-08-20

4.  Functional interactions of human immunodeficiency virus type 1 integrase with human and yeast HSP60.

Authors:  V Parissi; C Calmels; V R De Soultrait; A Caumont; M Fournier; S Chaignepain; S Litvak
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Accumulation and intranuclear distribution of unintegrated human immunodeficiency virus type 1 DNA.

Authors:  P Bell; L J Montaner; G G Maul
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Gene and cell therapy based treatment strategies for inflammatory bowel diseases.

Authors:  Sander van der Marel; Anna Majowicz; Sander van Deventer; Harald Petry; Daniel W Hommes; Valerie Ferreira
Journal:  World J Gastrointest Pathophysiol       Date:  2011-12-15

7.  Effective in vivo and ex vivo gene transfer to intestinal mucosa by VSV-G-pseudotyped lentiviral vectors.

Authors:  Hiroshi Matsumoto; Takahiro Kimura; Kazunori Haga; Noriyuki Kasahara; Peter Anton; Ian McGowan
Journal:  BMC Gastroenterol       Date:  2010-05-11       Impact factor: 3.067

8.  In vitro osteogenic differentiation of adipose stem cells after lentiviral transduction with green fluorescent protein.

Authors:  Qian Wang; Megan B Steigelman; John A Walker; Shuo Chen; Peter J Hornsby; Mary E Bohnenblust; Howard T Wang
Journal:  J Craniofac Surg       Date:  2009-11       Impact factor: 1.046

9.  Human immunodeficiency virus type 1 Vpr modulates cellular expression of UNG2 via a negative transcriptional effect.

Authors:  Christelle Langevin; Priscilla Maidou-Peindara; Per Arne Aas; Guillaume Jacquot; Marit Otterlei; Geir Slupphaug; Serge Benichou
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

10.  Inserting a nuclear targeting signal into a replication-competent Moloney murine leukemia virus affects viral export and is not sufficient for cell cycle-independent infection.

Authors:  Jennifer A Seamon; Kathryn S Jones; Christina Miller; Monica J Roth
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.